ArticleLeukemia research reports2024

Central nervous system relapse after combination therapy including polatuzumab vedotin in patients with diffuse large B-cell lymphoma.

Yoshikazu Hori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.